Cargando…
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
BACKGROUND: The aim of this in vitro study was to measure the enhanced anticancer effects of Res (resveratrol) on PA (paclitaxel) in HepG2 human liver cancer cells. METHODS: The MTT (thiazolyl blue tetrazolium bromide, 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), flow cytometry, qP...
Autores principales: | Jiang, Qin, Yang, Manyi, Qu, Zhan, Zhou, Jixiang, Zhang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628430/ https://www.ncbi.nlm.nih.gov/pubmed/28978315 http://dx.doi.org/10.1186/s12906-017-1956-0 |
Ejemplares similares
-
Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis
por: Zhou, Rui-sheng, et al.
Publicado: (2019) -
Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133(+) HepG2 liver cancer cells
por: Fu, Changhao, et al.
Publicado: (2019) -
Separation and Identification of Resveratrol Butyrate Ester Complexes and Their Bioactivity in HepG2 Cell Models
por: Shih, Ming-Kuei, et al.
Publicado: (2021) -
Sublethal hyperthermia enhances anticancer activity of doxorubicin in chronically hypoxic HepG2 cells through ROS-dependent mechanism
por: Wang, Qi, et al.
Publicado: (2021) -
HepG2-Based Designer Cells with Heat-Inducible Enhanced Liver Functions
por: Kitano, Hiroyuki, et al.
Publicado: (2022)